Market Research Logo

North America Pain Management Drugs Market Forecast 2019-2027

North America Pain Management Drugs Market Forecast 2019-2027

KEY FINDINGS

The North American pain management market is evolving at a CAGR of 3.62% during the forecasting years of 2019-2027. The respective growth can be reasoned to the humongous population of the aging generation in the region and the favorable regulatory conditions prevalent in the market. The United States and Canada are considered in the market study.

MARKETING INSIGHTS

There is a higher consumption rate of pain medication with fewer side-effects. This is a major attributing factor for the North America pain management market. Recent development in the technology for the advancement of abuse-deterrent drugs in the region is positively impacting the North American market. The United States market for pain management drug held the largest market share in 2018 due to favorable healthcare reforms in the country to improve the affordability of such medications.

COMPETITIVE INSIGHTS

GlaxoSmithKline, Purdue Pharma L.P., Acura Pharmaceuticals, Inc., Novartis, Daiichi Sankyo, Inc., Egalet Corp., Eli Lilly and Company, Insys Therapeutics, Inc., Abbott Laboratories, Hikma Pharmaceuticals PLC, Johnson & Johnson, Lupin Ltd., Pfizer, Inc., Merck & Co., Inc. and Cipher Pharmaceuticals Inc. are the eminent market players in the pain management market in the North America region.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Opioids Market Holds The Largest Market Share In Terms Of Drug Class
3.2.2. Cancer Pain Indication Is Anticipated To Grow At A Significant Rate
4. Market Dynamics
4.1. Market Scope & Definition
4.2. Market Drivers
4.2.1. Growth In The Incidence And Prevalence Of Chronic Diseases
4.2.2. The Rise In Awareness Regarding The Side-effects Of Pain Medication
4.2.3. Rise In Geriatric Population
4.3. Market Restraints
4.3.1. Accessibility Of Alternative Therapies
4.3.2. Increase In Drug Mistreatment
4.4. Market Opportunities
4.4.1. Technological Advancement
4.4.2. Growth Potential In Untapped Economies
4.5. Market Challenges
4.5.1. Patent Expiration
5. Market By Drug Class
5.1. Nsaids
5.2. Anesthetics
5.3. Anticonvulsants
5.4. Anti-migraine Agents
5.5. Antidepressants
5.6. Opioids
5.7. Non-narcotic Analgesics
6. Market By Indication
6.1. Arthritic Pain
6.2. Neuropathic Pain
6.3. Cancer Pain
6.4. Chronic Back Pain
6.5. Post-operative Pain
6.6. Migraine
6.7. Fibromyalgia
7. Key Analytics
7.1. Porter’s Five Force Model
7.1.1. Threat Of New Entrants
7.1.2. Threat Of Substitute
7.1.3. Bargaining Power Of Suppliers
7.1.4. Bargaining Power Of Buyers
7.1.5. Threat Of Competitive Rivalry
7.2. Regulatory Framework
7.3. Opportunity Matrix
7.4. Value Chain Analysis
7.5. Vendor Landscape
8. Geographical Analysis
8.1. North America
8.1.1. The United States
8.1.2. Canada
9. Competitive Landscape
9.1. Market Share Analysis
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.1.1. Company Overview
9.2.1.2. Product Portfolio
9.2.1.3. Scot Analysis
9.2.1.4. Strategic Initiatives
9.2.2. Acura Pharmaceuticals, Inc.
9.2.2.1. Company Overview
9.2.2.2. Product Portfolio
9.2.2.3. Strategic Initiatives
9.2.3. Cipher Pharmaceuticals Inc.
9.2.3.1. Company Overview
9.2.3.2. Product Portfolio
9.2.3.3. Strategic Initiatives
9.2.4. Daiichi Sankyo, Inc.
9.2.4.1. Company Overview
9.2.4.2. Product Portfolio
9.2.4.3. Strategic Initiatives
9.2.5. Egalet Corp.
9.2.5.1. Company Overview
9.2.5.2. Product Portfolio
9.2.5.3. Strategic Initiatives
9.2.6. Eli Lilly And Company
9.2.6.1. Company Overview
9.2.6.2. Product Portfolio
9.2.6.3. Scot Analysis
9.2.6.4. Strategic Initiatives
9.2.7. Glaxosmithkline
9.2.7.1. Company Overview
9.2.7.2. Product Portfolio
9.2.7.3. Scot Analysis
9.2.7.4. Strategic Initiatives
9.2.8. Hikma Pharmaceuticals Plc
9.2.8.1. Company Overview
9.2.8.2. Product Portfolio
9.2.8.3. Strategic Initiatives
9.2.9. Johnson & Johnson
9.2.9.1. Company Overview
9.2.9.2. Product Portfolio
9.2.9.3. Scot Analysis
9.2.9.4. Strategic Initiatives
9.2.10. Lupin Ltd.
9.2.10.1. Company Overview
9.2.10.2. Product Portfolio
9.2.10.3. Strategic Initiatives
9.2.11. Pfizer, Inc.
9.2.11.1. Company Profiles
9.2.11.2. Product Portfolio
9.2.11.3. Scot Analysis
9.2.11.4. Strategic Initiatives
9.2.12. Purdue Pharma L.P.
9.2.12.1. Company Overview
9.2.12.2. Product Portfolio
9.2.12.3. Strategic Initiatives
9.2.13. Merck & Co., Inc.
9.2.13.1. Company Profiles
9.2.13.2. Product Portfolio
9.2.13.3. Scot Analysis
9.2.13.4. Strategic Initiatives
9.2.14. Novartis
9.2.14.1. Company Overview
9.2.14.2. Product Portfolio
9.2.14.3. Scot Analysis
9.2.14.4. Strategic Initiatives
9.2.15. Insys Therapeutics, Inc.
9.2.15.1. Company Overview
9.2.15.2. Product Portfolio
9.2.15.3. Strategic Initiatives
Table List
Table 1 North America Pain Management Drugs Market 2019-2027 ($ Million)
Table 2 North America Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 3 North America Nsaids Market 2019-2027 ($ Million)
Table 4 North America Anesthetics Market 2019-2027 ($ Million)
Table 5 North America Anticonvulsants Market 2019-2027 ($ Million)
Table 6 North America Anti-migraine Agents Market 2019-2027 ($ Million)
Table 7 North America Antidepressants Market 2019-2027 ($ Million)
Table 8 North America Opioids Market 2019-2027 ($ Million)
Table 9 North America Non-narcotic Analgesics Market 2019-2027 ($ Million)
Table 10 North America Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 11 North America Arthritic Pain Market 2019-2027 ($ Million)
Table 12 North America Neuropathic Pain Market 2019-2027 ($ Million)
Table 13 North America Cancer Pain Market 2019-2027 ($ Million)
Table 14 North America Chronic Back Pain Market 2019-2027 ($ Million)
Table 15 North America Post-operative Pain Market 2019-2027 ($ Million)
Table 16 North America Migraine Market 2019-2027 ($ Million)
Table 17 North America Fibromyalgia Market 2019-2027 ($ Million)
Table 18 North America Pain Management Drugs Market 2019-2027 ($ Million)
Table 19 North America Pain Management Drugs Market By Country 2019-2027 ($ Million)
Table 20 The United States Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 21 The United States Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 22 Canada Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 23 Canada Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Figures List
Figure 1 North America Pain Management Drugs Market 2019-2027 ($ Million)
Figure 2 North America Pain Management Drugs Market Share By Drug Class 2018 & 2027 (%)
Figure 3 North America Pain Management Drugs Market By Nsaids 2019-2027 ($ Million)
Figure 4 North America Pain Management Drugs Market By Anesthetics 2019-2027 ($ Million)
Figure 5 North America Pain Management Drugs Market By Anticonvulsants 2019-2027 ($ Million)
Figure 6 North America Pain Management Drugs Market By Anti-migraine Agents 2019-2027 ($ Million)
Figure 7 North America Pain Management Drugs Market By Antidepressants 2019-2027 ($ Million)
Figure 8 North America Pain Management Drugs Market By Opioids 2019-2027 ($ Million)
Figure 9 North America Pain Management Drugs Market By Non-narcotic Analgesics 2019-2027 ($ Million)
Figure 10 North America Pain Management Drugs Market Share By Indication 2018 & 2027 (%)
Figure 11 North America Pain Management Drugs Market By Arthritic Pain 2019-2027 ($ Million)
Figure 12 North America Pain Management Drugs Market By Neuropathic Pain 2019-2027 ($ Million)
Figure 13 North America Pain Management Drugs Market By Cancer Pain 2019-2027 ($ Million)
Figure 14 North America Pain Management Drugs Market By Chronic Back Pain 2019-2027 ($ Million)
Figure 15 North America Pain Management Drugs Market By Post-operative Pain 2019-2027 ($ Million)
Figure 16 North America Pain Management Drugs Market By Migraine 2019-2027 ($ Million)
Figure 17 North America Pain Management Drugs Market By Fibromyalgia 2019-2027 ($ Million)
Figure 18 Porter’s Five Force Model
Figure 19 North America Pain Management Drugs Market Regional Outlook 2018 & 2027 (%)
Figure 20 The United States Pain Management Drugs Market 2019-2027 ($ Million)
Figure 21 Canada Pain Management Drugs Market 2019-2027 ($ Million)
Figure 22 Pain Management Market Share Analysis 2017 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report